CV.DISEASE.TRAIT
Abdominal aortic aneurysm
Aging traits
Ankle-brachial index
Anthracycline-induced cardiotoxicity in childhood cancer
Aortic-valve calcification
Aortic root size
Aortic stiffness
AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor
Arterial stiffness
Asymmetrical dimethylarginine levels
Atrial fibrillation
Atrial fibrillation/atrial flutter
Atrioventricular conduction
B-type natriuretic peptide
Behcet's disease
Biochemical measures
Biomedical quantitative traits
Blood pressure
Blood pressure (age interaction)
Brugada syndrome
C4b binding protein levels
Cardiac repolarization
Cardiac Troponin-T levels
Cardiovascular disease in hypertension (ACE inhibitor interaction)
Cardiovascular disease in hypertension (calcium channel blocker interaction)
Cardiovascular disease risk factors
Cardiovascular heart disease in diabetics
Carotid atherosclerosis in HIV infection
Carotid intima media thickness
Carotid plaque burden (smoking interaction)
Cerebral amyloid angiopathy
Cervical artery dissection
Chagas cardiomyopathy in Tripanosoma cruzi seropositivity
Chemerin levels
Circulating myeloperoxidase levels (plasma)
Circulating myeloperoxidase levels (serum)
Circulating vasoactive peptide levels
Congenital heart disease
Congenital heart malformation
Congenital left-sided heart lesions
Congenital left-sided heart lesions (maternal effect)
Conotruncal heart defects
Coronary artery aneurysm in Kawasaki disease
Coronary artery disease
Coronary artery disease or ischemic stroke
Coronary artery disease or large artery stroke
Coronary heart disease
Coronary heart disease event reduction in response to statin therapy (interaction)
Coronary restenosis
Coronary spasm
D-dimer levels
Diastolic blood pressure
Dilated cardiomyopathy
Drug-induced torsades de pointes
Ejection fraction in Tripanosoma cruzi seropositivity
Electrocardiographic conduction measures
Electrocardiographic traits
Endothelial growth factor levels
Exercise treadmill test traits
Fibrinogen
Gaucher disease severity
Heart failure
Heart rate
Heart rate variability traits
Hemostatic factors and hematological phenotypes
Hypertension
Hypertension (young onset)
Hypertension risk in short sleep duration
Intracerebral hemorrhage
Intracranial aneurysm
Ischemic stroke
Ischemic stroke (large artery atherosclerosis)
Large artery stroke
LDL (oxidized)
LDL cholesterol
Life threatening arrhythmia
Lipid levels in hepatitis C treatment
Lipid traits
Lipoprotein-associated phospholipase A2 activity and mass
Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
Lp (a) levels
Major CVD
Medication adherence in chronic diseases
Metabolite levels
Mortality in heart failure
Myocardial infarction
Myocardial infarction (early onset)
Myocardial infarction in coronary artery disease
Myocardial infarction in hypertension (calcium channel blocker interaction)
Natriuretic peptide levels
Obesity-related traits
Orthostatic hypotension
Osteoprotegerin levels
P wave duration
Paraoxonase activity
Perioperative myocardial infarction in coronary artery bypass surgery
Peripheral artery disease
Plasma cystastin c levels in acute coronary syndrome
Plasma plasminogen activator levels
Plasma renin activity levels
Platelet thrombus formation
Postoperative atrial fibrillation in coronary artery bypass grafting surgery
PR interval
PR interval in Tripanosoma cruzi seropositivity
PR segment
Preeclampsia
Protein quantitative trait loci
Pulmonary arterial hypertension (without BMPR2 mutations)
Pulse pressure
Pulse pressure (alcohol consumption interaction)
Pulse pressure in young-onset hypertension
QRS duration
QRS duration in Tripanosoma cruzi seropositivity
QT interval
QT interval (interaction)
QT interval in Tripanosoma cruzi seropositivity
Quantitative traits
Response to angiotensin II receptor blocker therapy
Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
Response to chemotherapy in breast cancer (hypertension) (bevacizumab)
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)
Response to Dalcetrapib treatment in acute coronary syndrome
Response to statins (LDL cholesterol change)
Resting heart rate
RR interval (heart rate)
Select biomarker traits
Serum protein levels (sST2)
Soluble ICAM-1
Soluble levels of adhesion molecules
Stroke
Stroke (ischemic)
Stroke (pediatric)
Subclinical atherosclerosis traits (other)
Sudden cardiac arrest
Symmetrical dimethylarginine levels
Systolic blood pressure
Thoracic aortic aneurysms and dissections
Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor
Trans fatty acid levels
Type 2 diabetes (young onset) and obesity
Urate levels
Vascular brain injury
Vascular dementia
Vascular endothelial growth factor levels
Venous thromboembolism
Venous thromboembolism (SNP x SNP interaction)
White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy
